Keywords: MR-Guided Interventions, Machine Learning/Artificial Intelligence, drug outcome estimation, seizure freedom
Motivation: Implementation of AI-driven precision medicine and finding the most effective Antiseizure Medications.
Goal(s): To predict outcomes of drug interventions in epilepsy patients and categorize them into distinct seizure outcome groups.
Approach: The research employs both patient characteristic, clinical, and MRI features going throguh a feature selection step followed by binary classification using Support Vector Machine, Naïve Bayes, Decision Tree, and Ridge Regression.
Results: Ridge regression combined with genetic algorithm outperformed the others, achieving an accuracy of 0.77 and AUC (Area Under the Curve) of 0.80 in predicting seizure outcome. This success was attained using a total of 18 MRI features and 10 ASMs.
Impact: Our model may help selection of the most effective ASM for individual patients. This may reduce the need for consecutive drug trials involving ineffective medications, thereby alleviating associated burdens.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords